Author:
Tan A. C. I. T. L.,Brouwer J. T.,Glue P.,van Leusen R.,Kauffmann R. H.,Schalm S. W.,de Vries R. A.,Vroom B.
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Reference5 articles.
1. Fabrizi F, Locatelli F. Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist. Nephrol Dial Transplant1999; 14: 2079–2081
2. Glue P. The clinical pharmacology of ribavirin. Semin Liver Dis1999; 19 [Suppl. 1]: 17–24
3. Khakoo S, Glue P, Grellier L et al. Ribavirin and interferon alpha‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. Br J Clin Pharmacol1998; 46: 563–570
4. Uchihara M, Izumi N, Sakai Y et al. Interferon therapy for chronic hepatitis C in hemodialysis patients: increased serum levels of interferon. Nephron1998; 80: 51–56
5. Catlin DH, Smith RA, Samuels AI. 14C‐ribavirin distribution and pharmacokinetic studies in rats, baboons and man. In: Smith RA, Kirkpatrick W, eds. Ribavirin: A Broad Spectrum Antiviral Agent. Academic Press, New York, 1980, 83–98
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献